US health insurer Cigna said on Thursday, March 8, it would buy pharmacy benefits manager Express Scripts for about US$52 billion; the latest deal in the sector aimed at tackling soaring healthcare costs.
US health insurer Cigna is close to buying St. Louis County-based pharmacy benefit manager Express Scripts, the Wall Street Journal reported late Wednesday, citing people familiar with the matter.
The terms of the potential deal were not released, but a deal could be announced anytime, the newspaper said. Express Scripts had a market value of US$41.43 billion as of Wednesday’s close, according to Thomson Reuters Eikon data.
Express Scripts spokesman Phil Blando declined to comment on the report Wednesday night, while Cigna could not be immediately reached for comment.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pork Industry Faces Legal Challenges as Antitrust Lawsuits Against Seaboard Foods Dismissed
Oct 2, 2024 by
CPI
CMA Strengthens Investigation with Advisory Panel of Veterinary Experts
Oct 2, 2024 by
CPI
US Merchants Sue Visa, Alleging Unfair Dominance in Debit Card Market
Oct 2, 2024 by
CPI
European Commission Appoints New Chief Competition Economist
Oct 2, 2024 by
CPI
EU Commission Requests Information from YouTube, Snapchat, TikTok on Algorithm Usage
Oct 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh